nodes	percent_of_prediction	percent_of_DWPC	metapath
Felodipine—CYP2D6—breast cancer	0.0892	0.389	CbGaD
Felodipine—CYP3A4—breast cancer	0.0765	0.333	CbGaD
Felodipine—ABCB1—breast cancer	0.0637	0.278	CbGaD
Felodipine—CYP2C9—Anastrozole—breast cancer	0.0172	0.0417	CbGbCtD
Felodipine—CYP3A5—Lapatinib—breast cancer	0.0171	0.0414	CbGbCtD
Felodipine—CYP2C8—Lapatinib—breast cancer	0.0164	0.0399	CbGbCtD
Felodipine—ABCB1—Toremifene—breast cancer	0.0153	0.037	CbGbCtD
Felodipine—CYP3A4—Exemestane—breast cancer	0.0132	0.032	CbGbCtD
Felodipine—CYP2C9—Idarubicin—breast cancer	0.013	0.0316	CbGbCtD
Felodipine—CYP2C8—Raloxifene—breast cancer	0.0125	0.0302	CbGbCtD
Felodipine—CYP2D6—Idarubicin—breast cancer	0.0119	0.0289	CbGbCtD
Felodipine—CYP3A7—Tamoxifen—breast cancer	0.0114	0.0277	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0114	0.0277	CbGbCtD
Felodipine—CYP3A4—Letrozole—breast cancer	0.0112	0.0272	CbGbCtD
Felodipine—ABCB1—Lapatinib—breast cancer	0.0111	0.027	CbGbCtD
Felodipine—CYP3A4—Anastrozole—breast cancer	0.00999	0.0242	CbGbCtD
Felodipine—CYP3A4—Toremifene—breast cancer	0.00914	0.0222	CbGbCtD
Felodipine—CYP3A7—Paclitaxel—breast cancer	0.00888	0.0215	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00888	0.0215	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00876	0.0212	CbGbCtD
Felodipine—CYP3A7—Irinotecan—breast cancer	0.00876	0.0212	CbGbCtD
Felodipine—CYP3A5—Tamoxifen—breast cancer	0.00856	0.0208	CbGbCtD
Felodipine—CYP3A4—Fulvestrant—breast cancer	0.0085	0.0206	CbGbCtD
Felodipine—CYP2C8—Tamoxifen—breast cancer	0.00823	0.02	CbGbCtD
Felodipine—CYP3A4—Thiotepa—breast cancer	0.00757	0.0184	CbGbCtD
Felodipine—CYP2C9—Capecitabine—breast cancer	0.00714	0.0173	CbGbCtD
Felodipine—CYP3A4—Ixabepilone—breast cancer	0.00693	0.0168	CbGbCtD
Felodipine—CYP3A4—Lapatinib—breast cancer	0.00667	0.0162	CbGbCtD
Felodipine—CYP3A5—Paclitaxel—breast cancer	0.00666	0.0162	CbGbCtD
Felodipine—CYP3A5—Irinotecan—breast cancer	0.00657	0.0159	CbGbCtD
Felodipine—CYP3A7—Docetaxel—breast cancer	0.00642	0.0156	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00642	0.0156	CbGbCtD
Felodipine—CYP2C8—Paclitaxel—breast cancer	0.00641	0.0155	CbGbCtD
Felodipine—ABCB1—Vinorelbine—breast cancer	0.00617	0.015	CbGbCtD
Felodipine—CYP2C8—Fluorouracil—breast cancer	0.00607	0.0147	CbGbCtD
Felodipine—CYP2D6—Vinorelbine—breast cancer	0.00582	0.0141	CbGbCtD
Felodipine—CYP2C9—Tamoxifen—breast cancer	0.00574	0.0139	CbGbCtD
Felodipine—ABCB1—Tamoxifen—breast cancer	0.00557	0.0135	CbGbCtD
Felodipine—ABCB1—Mitoxantrone—breast cancer	0.00543	0.0132	CbGbCtD
Felodipine—CYP2D6—Tamoxifen—breast cancer	0.00525	0.0127	CbGbCtD
Felodipine—CYP3A4—Raloxifene—breast cancer	0.00505	0.0122	CbGbCtD
Felodipine—CYP3A5—Docetaxel—breast cancer	0.00482	0.0117	CbGbCtD
Felodipine—ABCB1—Gemcitabine—breast cancer	0.0048	0.0116	CbGbCtD
Felodipine—CYP2C9—Paclitaxel—breast cancer	0.00447	0.0108	CbGbCtD
Felodipine—ABCB1—Paclitaxel—breast cancer	0.00434	0.0105	CbGbCtD
Felodipine—ABCB1—Irinotecan—breast cancer	0.00428	0.0104	CbGbCtD
Felodipine—CYP2C9—Fluorouracil—breast cancer	0.00423	0.0103	CbGbCtD
Felodipine—ABCB1—Vinblastine—breast cancer	0.0038	0.00922	CbGbCtD
Felodipine—CYP3A4—Vinorelbine—breast cancer	0.0037	0.00897	CbGbCtD
Felodipine—CYP2D6—Vinblastine—breast cancer	0.00358	0.00869	CbGbCtD
Felodipine—CYP3A4—Tamoxifen—breast cancer	0.00334	0.00809	CbGbCtD
Felodipine—CYP3A4—Mitoxantrone—breast cancer	0.00326	0.00789	CbGbCtD
Felodipine—ABCB1—Docetaxel—breast cancer	0.00314	0.0076	CbGbCtD
Felodipine—CYP3A4—Paclitaxel—breast cancer	0.0026	0.0063	CbGbCtD
Felodipine—CYP3A4—Irinotecan—breast cancer	0.00256	0.00621	CbGbCtD
Felodipine—ABCB1—Doxorubicin—breast cancer	0.00234	0.00567	CbGbCtD
Felodipine—CYP3A4—Vinblastine—breast cancer	0.00228	0.00552	CbGbCtD
Felodipine—ABCB1—Methotrexate—breast cancer	0.00226	0.00549	CbGbCtD
Felodipine—CYP2D6—Doxorubicin—breast cancer	0.0022	0.00534	CbGbCtD
Felodipine—CYP3A4—Docetaxel—breast cancer	0.00188	0.00455	CbGbCtD
Felodipine—TNNC2—adipose tissue—breast cancer	0.00179	0.03	CbGeAlD
Felodipine—CACNA2D2—mammary gland—breast cancer	0.00169	0.0282	CbGeAlD
Felodipine—TNNC2—female gonad—breast cancer	0.0015	0.0251	CbGeAlD
Felodipine—CYP3A4—Doxorubicin—breast cancer	0.0014	0.00339	CbGbCtD
Felodipine—TNNC2—endocrine gland—breast cancer	0.0014	0.0233	CbGeAlD
Felodipine—CACNA2D1—mammary gland—breast cancer	0.00122	0.0203	CbGeAlD
Felodipine—TNNC1—endometrium—breast cancer	0.001	0.0168	CbGeAlD
Felodipine—TNNC2—lymph node—breast cancer	0.000965	0.0161	CbGeAlD
Felodipine—PDE1B—adipose tissue—breast cancer	0.000943	0.0158	CbGeAlD
Felodipine—TNNC1—pituitary gland—breast cancer	0.000908	0.0152	CbGeAlD
Felodipine—TNNC1—adipose tissue—breast cancer	0.000904	0.0151	CbGeAlD
Felodipine—CALM3—mammary gland—breast cancer	0.000875	0.0146	CbGeAlD
Felodipine—PDE1B—female reproductive system—breast cancer	0.000867	0.0145	CbGeAlD
Felodipine—PDE1B—adrenal gland—breast cancer	0.000846	0.0141	CbGeAlD
Felodipine—TNNC1—adrenal gland—breast cancer	0.000811	0.0136	CbGeAlD
Felodipine—PDE1A—uterus—breast cancer	0.000808	0.0135	CbGeAlD
Felodipine—PDE1A—adipose tissue—breast cancer	0.00079	0.0132	CbGeAlD
Felodipine—NR3C2—nipple—breast cancer	0.000786	0.0131	CbGeAlD
Felodipine—CACNA2D2—pituitary gland—breast cancer	0.000764	0.0128	CbGeAlD
Felodipine—PDE1B—endocrine gland—breast cancer	0.000733	0.0123	CbGeAlD
Felodipine—PDE1A—female reproductive system—breast cancer	0.000726	0.0121	CbGeAlD
Felodipine—CALM3—nipple—breast cancer	0.000723	0.0121	CbGeAlD
Felodipine—PDE1A—adrenal gland—breast cancer	0.000709	0.0118	CbGeAlD
Felodipine—CALM1—mammary gland—breast cancer	0.000684	0.0114	CbGeAlD
Felodipine—CACNA2D2—adrenal gland—breast cancer	0.000682	0.0114	CbGeAlD
Felodipine—PDE1A—female gonad—breast cancer	0.000661	0.011	CbGeAlD
Felodipine—CACNA1H—uterus—breast cancer	0.000631	0.0105	CbGeAlD
Felodipine—CACNA1H—pituitary gland—breast cancer	0.000619	0.0104	CbGeAlD
Felodipine—PDE1A—endocrine gland—breast cancer	0.000615	0.0103	CbGeAlD
Felodipine—CACNA2D2—endocrine gland—breast cancer	0.000592	0.00989	CbGeAlD
Felodipine—CACNB2—pituitary gland—breast cancer	0.000585	0.00978	CbGeAlD
Felodipine—CYP2C8—mammary gland—breast cancer	0.000569	0.00952	CbGeAlD
Felodipine—CALM2—nipple—breast cancer	0.000568	0.0095	CbGeAlD
Felodipine—CACNA1H—female reproductive system—breast cancer	0.000567	0.00948	CbGeAlD
Felodipine—CALM1—nipple—breast cancer	0.000566	0.00945	CbGeAlD
Felodipine—CACNA1H—adrenal gland—breast cancer	0.000553	0.00925	CbGeAlD
Felodipine—CACNA2D1—adipose tissue—breast cancer	0.000547	0.00915	CbGeAlD
Felodipine—Nimodipine—AHR—breast cancer	0.000539	0.175	CrCbGaD
Felodipine—CACNB2—adrenal gland—breast cancer	0.000523	0.00873	CbGeAlD
Felodipine—CACNA1H—female gonad—breast cancer	0.000516	0.00862	CbGeAlD
Felodipine—CACNA1D—pituitary gland—breast cancer	0.000511	0.00855	CbGeAlD
Felodipine—CYP3A7—endocrine gland—breast cancer	0.000511	0.00854	CbGeAlD
Felodipine—PDE1B—lymph node—breast cancer	0.000507	0.00848	CbGeAlD
Felodipine—CYP2C9—mammary gland—breast cancer	0.000506	0.00845	CbGeAlD
Felodipine—CACNA2D1—adrenal gland—breast cancer	0.000491	0.0082	CbGeAlD
Felodipine—TNNC1—lymph node—breast cancer	0.000486	0.00813	CbGeAlD
Felodipine—CACNA1H—endocrine gland—breast cancer	0.00048	0.00802	CbGeAlD
Felodipine—CACNA2D1—bone marrow—breast cancer	0.000475	0.00794	CbGeAlD
Felodipine—NR3C2—endometrium—breast cancer	0.000475	0.00794	CbGeAlD
Felodipine—CACNA1C—pituitary gland—breast cancer	0.000472	0.00789	CbGeAlD
Felodipine—CACNA1C—adipose tissue—breast cancer	0.00047	0.00786	CbGeAlD
Felodipine—CALM2—embryo—breast cancer	0.000469	0.00784	CbGeAlD
Felodipine—CALM1—embryo—breast cancer	0.000467	0.0078	CbGeAlD
Felodipine—CACNA2D1—female gonad—breast cancer	0.000458	0.00765	CbGeAlD
Felodipine—CACNA1D—adrenal gland—breast cancer	0.000457	0.00763	CbGeAlD
Felodipine—NR3C2—uterus—breast cancer	0.000437	0.00731	CbGeAlD
Felodipine—CALM3—endometrium—breast cancer	0.000437	0.0073	CbGeAlD
Felodipine—CACNA1C—female reproductive system—breast cancer	0.000432	0.00722	CbGeAlD
Felodipine—NR3C2—pituitary gland—breast cancer	0.00043	0.00718	CbGeAlD
Felodipine—NR3C2—adipose tissue—breast cancer	0.000428	0.00715	CbGeAlD
Felodipine—CACNA2D1—endocrine gland—breast cancer	0.000426	0.00711	CbGeAlD
Felodipine—PDE1A—lymph node—breast cancer	0.000425	0.0071	CbGeAlD
Felodipine—CACNA1C—adrenal gland—breast cancer	0.000422	0.00705	CbGeAlD
Felodipine—CACNA2D2—lymph node—breast cancer	0.000409	0.00684	CbGeAlD
Felodipine—CALM3—uterus—breast cancer	0.000403	0.00673	CbGeAlD
Felodipine—CACNA1D—endocrine gland—breast cancer	0.000396	0.00662	CbGeAlD
Felodipine—CALM3—pituitary gland—breast cancer	0.000395	0.00661	CbGeAlD
Felodipine—CALM3—adipose tissue—breast cancer	0.000394	0.00658	CbGeAlD
Felodipine—NR3C2—female reproductive system—breast cancer	0.000393	0.00657	CbGeAlD
Felodipine—NR3C2—adrenal gland—breast cancer	0.000384	0.00642	CbGeAlD
Felodipine—CALM2—epithelium—breast cancer	0.000383	0.00639	CbGeAlD
Felodipine—CALM1—epithelium—breast cancer	0.000381	0.00637	CbGeAlD
Felodipine—CACNA1C—endocrine gland—breast cancer	0.000366	0.00611	CbGeAlD
Felodipine—CALM2—skin of body—breast cancer	0.000364	0.00608	CbGeAlD
Felodipine—CALM1—skin of body—breast cancer	0.000362	0.00605	CbGeAlD
Felodipine—NR3C2—female gonad—breast cancer	0.000358	0.00598	CbGeAlD
Felodipine—CALM3—adrenal gland—breast cancer	0.000353	0.0059	CbGeAlD
Felodipine—CALM2—endometrium—breast cancer	0.000343	0.00573	CbGeAlD
Felodipine—CALM3—bone marrow—breast cancer	0.000342	0.00571	CbGeAlD
Felodipine—CALM1—endometrium—breast cancer	0.000341	0.00571	CbGeAlD
Felodipine—NR3C2—endocrine gland—breast cancer	0.000333	0.00556	CbGeAlD
Felodipine—CACNA1H—lymph node—breast cancer	0.000332	0.00554	CbGeAlD
Felodipine—CALM3—female gonad—breast cancer	0.000329	0.0055	CbGeAlD
Felodipine—CALM2—uterus—breast cancer	0.000316	0.00528	CbGeAlD
Felodipine—CALM1—uterus—breast cancer	0.000315	0.00526	CbGeAlD
Felodipine—CACNB2—lymph node—breast cancer	0.000313	0.00524	CbGeAlD
Felodipine—CALM2—pituitary gland—breast cancer	0.00031	0.00519	CbGeAlD
Felodipine—CALM2—adipose tissue—breast cancer	0.000309	0.00517	CbGeAlD
Felodipine—CALM1—pituitary gland—breast cancer	0.000309	0.00517	CbGeAlD
Felodipine—CALM1—adipose tissue—breast cancer	0.000308	0.00514	CbGeAlD
Felodipine—CACNA2D1—lymph node—breast cancer	0.000294	0.00492	CbGeAlD
Felodipine—CYP2C8—endometrium—breast cancer	0.000284	0.00475	CbGeAlD
Felodipine—CALM2—female reproductive system—breast cancer	0.000284	0.00475	CbGeAlD
Felodipine—CALM1—female reproductive system—breast cancer	0.000283	0.00473	CbGeAlD
Felodipine—CALM2—adrenal gland—breast cancer	0.000277	0.00464	CbGeAlD
Felodipine—CALM1—adrenal gland—breast cancer	0.000276	0.00461	CbGeAlD
Felodipine—CACNA1D—lymph node—breast cancer	0.000274	0.00458	CbGeAlD
Felodipine—CALM2—bone marrow—breast cancer	0.000268	0.00448	CbGeAlD
Felodipine—CALM1—bone marrow—breast cancer	0.000267	0.00446	CbGeAlD
Felodipine—CALM2—female gonad—breast cancer	0.000259	0.00432	CbGeAlD
Felodipine—CALM1—female gonad—breast cancer	0.000257	0.0043	CbGeAlD
Felodipine—CYP2C8—pituitary gland—breast cancer	0.000257	0.0043	CbGeAlD
Felodipine—CACNA1C—lymph node—breast cancer	0.000253	0.00422	CbGeAlD
Felodipine—Clevidipine—BCHE—breast cancer	0.000245	0.0794	CrCbGaD
Felodipine—CALM2—endocrine gland—breast cancer	0.00024	0.00402	CbGeAlD
Felodipine—CALM1—endocrine gland—breast cancer	0.000239	0.004	CbGeAlD
Felodipine—CYP2C8—female reproductive system—breast cancer	0.000236	0.00394	CbGeAlD
Felodipine—CYP3A5—adipose tissue—breast cancer	0.000231	0.00387	CbGeAlD
Felodipine—NR3C2—lymph node—breast cancer	0.00023	0.00385	CbGeAlD
Felodipine—CALM3—lymph node—breast cancer	0.000212	0.00354	CbGeAlD
Felodipine—CYP2C9—female reproductive system—breast cancer	0.000209	0.0035	CbGeAlD
Felodipine—CYP2C8—endocrine gland—breast cancer	0.000199	0.00333	CbGeAlD
Felodipine—CYP3A5—female gonad—breast cancer	0.000193	0.00323	CbGeAlD
Felodipine—ABCB1—embryo—breast cancer	0.000186	0.00311	CbGeAlD
Felodipine—CYP3A5—endocrine gland—breast cancer	0.00018	0.00301	CbGeAlD
Felodipine—CYP2C9—endocrine gland—breast cancer	0.000177	0.00296	CbGeAlD
Felodipine—Lercanidipine—CYP2D6—breast cancer	0.000169	0.0547	CrCbGaD
Felodipine—CALM2—lymph node—breast cancer	0.000166	0.00278	CbGeAlD
Felodipine—CALM1—lymph node—breast cancer	0.000165	0.00277	CbGeAlD
Felodipine—CYP3A4—female reproductive system—breast cancer	0.00016	0.00267	CbGeAlD
Felodipine—CYP2D6—female reproductive system—breast cancer	0.000157	0.00262	CbGeAlD
Felodipine—ABCB1—epithelium—breast cancer	0.000152	0.00254	CbGeAlD
Felodipine—Lercanidipine—CYP3A4—breast cancer	0.000145	0.0469	CrCbGaD
Felodipine—CYP2D6—female gonad—breast cancer	0.000143	0.00239	CbGeAlD
Felodipine—Amlodipine—CYP1A1—breast cancer	0.000139	0.0452	CrCbGaD
Felodipine—ABCB1—endometrium—breast cancer	0.000136	0.00228	CbGeAlD
Felodipine—CYP3A4—endocrine gland—breast cancer	0.000135	0.00226	CbGeAlD
Felodipine—Clevidipine—CYP2D6—breast cancer	0.000134	0.0436	CrCbGaD
Felodipine—CYP2D6—endocrine gland—breast cancer	0.000133	0.00222	CbGeAlD
Felodipine—Isradipine—CYP3A4—breast cancer	0.000131	0.0424	CrCbGaD
Felodipine—ABCB1—uterus—breast cancer	0.000126	0.0021	CbGeAlD
Felodipine—Nifedipine—CYP1A1—breast cancer	0.000125	0.0404	CrCbGaD
Felodipine—ABCB1—pituitary gland—breast cancer	0.000123	0.00206	CbGeAlD
Felodipine—ABCB1—adipose tissue—breast cancer	0.000123	0.00205	CbGeAlD
Felodipine—Clevidipine—CYP3A4—breast cancer	0.000115	0.0374	CrCbGaD
Felodipine—ABCB1—female reproductive system—breast cancer	0.000113	0.00189	CbGeAlD
Felodipine—Nisoldipine—CYP3A4—breast cancer	0.00011	0.0358	CrCbGaD
Felodipine—ABCB1—adrenal gland—breast cancer	0.00011	0.00184	CbGeAlD
Felodipine—Nimodipine—CYP3A4—breast cancer	0.000107	0.0346	CrCbGaD
Felodipine—ABCB1—bone marrow—breast cancer	0.000107	0.00178	CbGeAlD
Felodipine—Amlodipine—CYP2D6—breast cancer	0.000104	0.0336	CrCbGaD
Felodipine—Nitrendipine—CYP3A4—breast cancer	0.000103	0.0335	CrCbGaD
Felodipine—Nilvadipine—CYP3A4—breast cancer	0.000103	0.0335	CrCbGaD
Felodipine—ABCB1—female gonad—breast cancer	0.000103	0.00172	CbGeAlD
Felodipine—ABCB1—endocrine gland—breast cancer	9.56e-05	0.0016	CbGeAlD
Felodipine—Nifedipine—CYP2D6—breast cancer	9.27e-05	0.0301	CrCbGaD
Felodipine—Nisoldipine—ABCB1—breast cancer	9.19e-05	0.0298	CrCbGaD
Felodipine—Nicardipine—CYP2D6—breast cancer	9.12e-05	0.0296	CrCbGaD
Felodipine—Amlodipine—CYP3A4—breast cancer	8.89e-05	0.0289	CrCbGaD
Felodipine—Nitrendipine—ABCB1—breast cancer	8.6e-05	0.0279	CrCbGaD
Felodipine—Nifedipine—CYP3A4—breast cancer	7.95e-05	0.0258	CrCbGaD
Felodipine—Nicardipine—CYP3A4—breast cancer	7.83e-05	0.0254	CrCbGaD
Felodipine—Amlodipine—ABCB1—breast cancer	7.4e-05	0.024	CrCbGaD
Felodipine—Nifedipine—ABCB1—breast cancer	6.62e-05	0.0215	CrCbGaD
Felodipine—ABCB1—lymph node—breast cancer	6.61e-05	0.0011	CbGeAlD
Felodipine—Nicardipine—ABCB1—breast cancer	6.52e-05	0.0211	CrCbGaD
Felodipine—Myalgia—Docetaxel—breast cancer	6.04e-05	0.000404	CcSEcCtD
Felodipine—Loss of consciousness—Capecitabine—breast cancer	6.04e-05	0.000404	CcSEcCtD
Felodipine—Nausea—Vinorelbine—breast cancer	6.03e-05	0.000404	CcSEcCtD
Felodipine—Dyspepsia—Paclitaxel—breast cancer	6.01e-05	0.000403	CcSEcCtD
Felodipine—Asthenia—Irinotecan—breast cancer	6.01e-05	0.000402	CcSEcCtD
Felodipine—Asthenia—Mitoxantrone—breast cancer	6.01e-05	0.000402	CcSEcCtD
Felodipine—Cough—Capecitabine—breast cancer	5.99e-05	0.000401	CcSEcCtD
Felodipine—Dysuria—Doxorubicin—breast cancer	5.94e-05	0.000398	CcSEcCtD
Felodipine—Hypersensitivity—Fluorouracil—breast cancer	5.91e-05	0.000396	CcSEcCtD
Felodipine—Dry mouth—Docetaxel—breast cancer	5.91e-05	0.000395	CcSEcCtD
Felodipine—Upper respiratory tract infection—Doxorubicin—breast cancer	5.91e-05	0.000395	CcSEcCtD
Felodipine—Fatigue—Paclitaxel—breast cancer	5.89e-05	0.000394	CcSEcCtD
Felodipine—Pollakiuria—Doxorubicin—breast cancer	5.87e-05	0.000393	CcSEcCtD
Felodipine—Asthenia—Gemcitabine—breast cancer	5.85e-05	0.000392	CcSEcCtD
Felodipine—Myalgia—Capecitabine—breast cancer	5.85e-05	0.000391	CcSEcCtD
Felodipine—Arthralgia—Capecitabine—breast cancer	5.85e-05	0.000391	CcSEcCtD
Felodipine—Chest pain—Capecitabine—breast cancer	5.85e-05	0.000391	CcSEcCtD
Felodipine—Constipation—Paclitaxel—breast cancer	5.84e-05	0.000391	CcSEcCtD
Felodipine—Confusional state—Docetaxel—breast cancer	5.84e-05	0.000391	CcSEcCtD
Felodipine—Pharyngitis—Methotrexate—breast cancer	5.83e-05	0.00039	CcSEcCtD
Felodipine—Photosensitivity reaction—Doxorubicin—breast cancer	5.8e-05	0.000388	CcSEcCtD
Felodipine—Epistaxis—Epirubicin—breast cancer	5.78e-05	0.000387	CcSEcCtD
Felodipine—Pruritus—Gemcitabine—breast cancer	5.77e-05	0.000386	CcSEcCtD
Felodipine—Nausea—Thiotepa—breast cancer	5.76e-05	0.000386	CcSEcCtD
Felodipine—Sinusitis—Epirubicin—breast cancer	5.75e-05	0.000385	CcSEcCtD
Felodipine—Diarrhoea—Mitoxantrone—breast cancer	5.73e-05	0.000384	CcSEcCtD
Felodipine—Diarrhoea—Irinotecan—breast cancer	5.73e-05	0.000384	CcSEcCtD
Felodipine—Dry mouth—Capecitabine—breast cancer	5.72e-05	0.000383	CcSEcCtD
Felodipine—Shock—Docetaxel—breast cancer	5.7e-05	0.000381	CcSEcCtD
Felodipine—Pruritus—Fluorouracil—breast cancer	5.68e-05	0.00038	CcSEcCtD
Felodipine—Visual impairment—Methotrexate—breast cancer	5.66e-05	0.000379	CcSEcCtD
Felodipine—Confusional state—Capecitabine—breast cancer	5.65e-05	0.000378	CcSEcCtD
Felodipine—Tachycardia—Docetaxel—breast cancer	5.65e-05	0.000378	CcSEcCtD
Felodipine—Feeling abnormal—Paclitaxel—breast cancer	5.63e-05	0.000377	CcSEcCtD
Felodipine—Bradycardia—Epirubicin—breast cancer	5.6e-05	0.000375	CcSEcCtD
Felodipine—Gastrointestinal pain—Paclitaxel—breast cancer	5.59e-05	0.000374	CcSEcCtD
Felodipine—Diarrhoea—Gemcitabine—breast cancer	5.58e-05	0.000374	CcSEcCtD
Felodipine—Erythema multiforme—Methotrexate—breast cancer	5.55e-05	0.000372	CcSEcCtD
Felodipine—Dizziness—Irinotecan—breast cancer	5.54e-05	0.000371	CcSEcCtD
Felodipine—Shock—Capecitabine—breast cancer	5.52e-05	0.000369	CcSEcCtD
Felodipine—Diarrhoea—Fluorouracil—breast cancer	5.49e-05	0.000367	CcSEcCtD
Felodipine—Tachycardia—Capecitabine—breast cancer	5.47e-05	0.000366	CcSEcCtD
Felodipine—Pharyngitis—Epirubicin—breast cancer	5.46e-05	0.000365	CcSEcCtD
Felodipine—Urticaria—Paclitaxel—breast cancer	5.43e-05	0.000363	CcSEcCtD
Felodipine—Oedema peripheral—Epirubicin—breast cancer	5.42e-05	0.000363	CcSEcCtD
Felodipine—Body temperature increased—Paclitaxel—breast cancer	5.4e-05	0.000362	CcSEcCtD
Felodipine—Abdominal pain—Paclitaxel—breast cancer	5.4e-05	0.000362	CcSEcCtD
Felodipine—Epistaxis—Doxorubicin—breast cancer	5.34e-05	0.000358	CcSEcCtD
Felodipine—Vomiting—Mitoxantrone—breast cancer	5.33e-05	0.000357	CcSEcCtD
Felodipine—Vomiting—Irinotecan—breast cancer	5.33e-05	0.000357	CcSEcCtD
Felodipine—Sinusitis—Doxorubicin—breast cancer	5.32e-05	0.000356	CcSEcCtD
Felodipine—Dizziness—Fluorouracil—breast cancer	5.31e-05	0.000355	CcSEcCtD
Felodipine—Visual impairment—Epirubicin—breast cancer	5.3e-05	0.000355	CcSEcCtD
Felodipine—Rash—Mitoxantrone—breast cancer	5.28e-05	0.000354	CcSEcCtD
Felodipine—Rash—Irinotecan—breast cancer	5.28e-05	0.000354	CcSEcCtD
Felodipine—Dermatitis—Irinotecan—breast cancer	5.28e-05	0.000353	CcSEcCtD
Felodipine—Dermatitis—Mitoxantrone—breast cancer	5.28e-05	0.000353	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Docetaxel—breast cancer	5.28e-05	0.000353	CcSEcCtD
Felodipine—Headache—Mitoxantrone—breast cancer	5.25e-05	0.000351	CcSEcCtD
Felodipine—Headache—Irinotecan—breast cancer	5.25e-05	0.000351	CcSEcCtD
Felodipine—Insomnia—Docetaxel—breast cancer	5.24e-05	0.000351	CcSEcCtD
Felodipine—Paraesthesia—Docetaxel—breast cancer	5.2e-05	0.000348	CcSEcCtD
Felodipine—Erythema multiforme—Epirubicin—breast cancer	5.2e-05	0.000348	CcSEcCtD
Felodipine—Vomiting—Gemcitabine—breast cancer	5.19e-05	0.000347	CcSEcCtD
Felodipine—Bradycardia—Doxorubicin—breast cancer	5.18e-05	0.000347	CcSEcCtD
Felodipine—Dyspnoea—Docetaxel—breast cancer	5.16e-05	0.000346	CcSEcCtD
Felodipine—Somnolence—Docetaxel—breast cancer	5.15e-05	0.000345	CcSEcCtD
Felodipine—Rash—Gemcitabine—breast cancer	5.14e-05	0.000344	CcSEcCtD
Felodipine—Dermatitis—Gemcitabine—breast cancer	5.14e-05	0.000344	CcSEcCtD
Felodipine—Erythema—Methotrexate—breast cancer	5.11e-05	0.000342	CcSEcCtD
Felodipine—Headache—Gemcitabine—breast cancer	5.11e-05	0.000342	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Capecitabine—breast cancer	5.11e-05	0.000342	CcSEcCtD
Felodipine—Flushing—Epirubicin—breast cancer	5.1e-05	0.000342	CcSEcCtD
Felodipine—Vomiting—Fluorouracil—breast cancer	5.1e-05	0.000341	CcSEcCtD
Felodipine—Dyspepsia—Docetaxel—breast cancer	5.1e-05	0.000341	CcSEcCtD
Felodipine—Insomnia—Capecitabine—breast cancer	5.07e-05	0.000339	CcSEcCtD
Felodipine—Rash—Fluorouracil—breast cancer	5.06e-05	0.000339	CcSEcCtD
Felodipine—Dermatitis—Fluorouracil—breast cancer	5.05e-05	0.000338	CcSEcCtD
Felodipine—Pharyngitis—Doxorubicin—breast cancer	5.05e-05	0.000338	CcSEcCtD
Felodipine—Paraesthesia—Capecitabine—breast cancer	5.03e-05	0.000337	CcSEcCtD
Felodipine—Hypersensitivity—Paclitaxel—breast cancer	5.03e-05	0.000337	CcSEcCtD
Felodipine—Headache—Fluorouracil—breast cancer	5.03e-05	0.000336	CcSEcCtD
Felodipine—Oedema peripheral—Doxorubicin—breast cancer	5.01e-05	0.000335	CcSEcCtD
Felodipine—Dyspnoea—Capecitabine—breast cancer	5e-05	0.000335	CcSEcCtD
Felodipine—Fatigue—Docetaxel—breast cancer	4.99e-05	0.000334	CcSEcCtD
Felodipine—Nausea—Mitoxantrone—breast cancer	4.98e-05	0.000333	CcSEcCtD
Felodipine—Nausea—Irinotecan—breast cancer	4.98e-05	0.000333	CcSEcCtD
Felodipine—Constipation—Docetaxel—breast cancer	4.95e-05	0.000331	CcSEcCtD
Felodipine—Back pain—Methotrexate—breast cancer	4.95e-05	0.000331	CcSEcCtD
Felodipine—Dyspepsia—Capecitabine—breast cancer	4.94e-05	0.00033	CcSEcCtD
Felodipine—Arrhythmia—Epirubicin—breast cancer	4.91e-05	0.000329	CcSEcCtD
Felodipine—Visual impairment—Doxorubicin—breast cancer	4.9e-05	0.000328	CcSEcCtD
Felodipine—Asthenia—Paclitaxel—breast cancer	4.9e-05	0.000328	CcSEcCtD
Felodipine—Nausea—Gemcitabine—breast cancer	4.85e-05	0.000324	CcSEcCtD
Felodipine—Fatigue—Capecitabine—breast cancer	4.83e-05	0.000324	CcSEcCtD
Felodipine—Pruritus—Paclitaxel—breast cancer	4.83e-05	0.000324	CcSEcCtD
Felodipine—Erythema multiforme—Doxorubicin—breast cancer	4.81e-05	0.000322	CcSEcCtD
Felodipine—Constipation—Capecitabine—breast cancer	4.79e-05	0.000321	CcSEcCtD
Felodipine—Erythema—Epirubicin—breast cancer	4.79e-05	0.00032	CcSEcCtD
Felodipine—Feeling abnormal—Docetaxel—breast cancer	4.77e-05	0.000319	CcSEcCtD
Felodipine—Nausea—Fluorouracil—breast cancer	4.77e-05	0.000319	CcSEcCtD
Felodipine—Gastrointestinal pain—Docetaxel—breast cancer	4.74e-05	0.000317	CcSEcCtD
Felodipine—Anaemia—Methotrexate—breast cancer	4.73e-05	0.000316	CcSEcCtD
Felodipine—Flushing—Doxorubicin—breast cancer	4.72e-05	0.000316	CcSEcCtD
Felodipine—Flatulence—Epirubicin—breast cancer	4.72e-05	0.000316	CcSEcCtD
Felodipine—Tension—Epirubicin—breast cancer	4.7e-05	0.000314	CcSEcCtD
Felodipine—Diarrhoea—Paclitaxel—breast cancer	4.67e-05	0.000313	CcSEcCtD
Felodipine—Nervousness—Epirubicin—breast cancer	4.65e-05	0.000311	CcSEcCtD
Felodipine—Back pain—Epirubicin—breast cancer	4.63e-05	0.00031	CcSEcCtD
Felodipine—Feeling abnormal—Capecitabine—breast cancer	4.62e-05	0.000309	CcSEcCtD
Felodipine—Muscle spasms—Epirubicin—breast cancer	4.6e-05	0.000308	CcSEcCtD
Felodipine—Vertigo—Methotrexate—breast cancer	4.59e-05	0.000308	CcSEcCtD
Felodipine—Gastrointestinal pain—Capecitabine—breast cancer	4.58e-05	0.000307	CcSEcCtD
Felodipine—Body temperature increased—Docetaxel—breast cancer	4.58e-05	0.000306	CcSEcCtD
Felodipine—Abdominal pain—Docetaxel—breast cancer	4.58e-05	0.000306	CcSEcCtD
Felodipine—Arrhythmia—Doxorubicin—breast cancer	4.54e-05	0.000304	CcSEcCtD
Felodipine—Dizziness—Paclitaxel—breast cancer	4.52e-05	0.000302	CcSEcCtD
Felodipine—Cough—Methotrexate—breast cancer	4.46e-05	0.000299	CcSEcCtD
Felodipine—Urticaria—Capecitabine—breast cancer	4.45e-05	0.000298	CcSEcCtD
Felodipine—Abdominal pain—Capecitabine—breast cancer	4.43e-05	0.000297	CcSEcCtD
Felodipine—Body temperature increased—Capecitabine—breast cancer	4.43e-05	0.000297	CcSEcCtD
Felodipine—Erythema—Doxorubicin—breast cancer	4.43e-05	0.000296	CcSEcCtD
Felodipine—Anaemia—Epirubicin—breast cancer	4.42e-05	0.000296	CcSEcCtD
Felodipine—Flatulence—Doxorubicin—breast cancer	4.36e-05	0.000292	CcSEcCtD
Felodipine—Myalgia—Methotrexate—breast cancer	4.35e-05	0.000291	CcSEcCtD
Felodipine—Arthralgia—Methotrexate—breast cancer	4.35e-05	0.000291	CcSEcCtD
Felodipine—Chest pain—Methotrexate—breast cancer	4.35e-05	0.000291	CcSEcCtD
Felodipine—Tension—Doxorubicin—breast cancer	4.35e-05	0.000291	CcSEcCtD
Felodipine—Vomiting—Paclitaxel—breast cancer	4.34e-05	0.000291	CcSEcCtD
Felodipine—Rash—Paclitaxel—breast cancer	4.31e-05	0.000288	CcSEcCtD
Felodipine—Dermatitis—Paclitaxel—breast cancer	4.3e-05	0.000288	CcSEcCtD
Felodipine—Nervousness—Doxorubicin—breast cancer	4.3e-05	0.000288	CcSEcCtD
Felodipine—Vertigo—Epirubicin—breast cancer	4.3e-05	0.000288	CcSEcCtD
Felodipine—Syncope—Epirubicin—breast cancer	4.29e-05	0.000287	CcSEcCtD
Felodipine—Back pain—Doxorubicin—breast cancer	4.28e-05	0.000287	CcSEcCtD
Felodipine—Headache—Paclitaxel—breast cancer	4.28e-05	0.000286	CcSEcCtD
Felodipine—Hypersensitivity—Docetaxel—breast cancer	4.27e-05	0.000286	CcSEcCtD
Felodipine—Muscle spasms—Doxorubicin—breast cancer	4.26e-05	0.000285	CcSEcCtD
Felodipine—Palpitations—Epirubicin—breast cancer	4.23e-05	0.000283	CcSEcCtD
Felodipine—Confusional state—Methotrexate—breast cancer	4.21e-05	0.000282	CcSEcCtD
Felodipine—Loss of consciousness—Epirubicin—breast cancer	4.21e-05	0.000282	CcSEcCtD
Felodipine—Cough—Epirubicin—breast cancer	4.18e-05	0.00028	CcSEcCtD
Felodipine—Asthenia—Docetaxel—breast cancer	4.15e-05	0.000278	CcSEcCtD
Felodipine—Hypersensitivity—Capecitabine—breast cancer	4.13e-05	0.000276	CcSEcCtD
Felodipine—Pruritus—Docetaxel—breast cancer	4.1e-05	0.000274	CcSEcCtD
Felodipine—Anaemia—Doxorubicin—breast cancer	4.09e-05	0.000274	CcSEcCtD
Felodipine—Chest pain—Epirubicin—breast cancer	4.07e-05	0.000273	CcSEcCtD
Felodipine—Myalgia—Epirubicin—breast cancer	4.07e-05	0.000273	CcSEcCtD
Felodipine—Arthralgia—Epirubicin—breast cancer	4.07e-05	0.000273	CcSEcCtD
Felodipine—Nausea—Paclitaxel—breast cancer	4.06e-05	0.000272	CcSEcCtD
Felodipine—Asthenia—Capecitabine—breast cancer	4.02e-05	0.000269	CcSEcCtD
Felodipine—Dry mouth—Epirubicin—breast cancer	3.98e-05	0.000267	CcSEcCtD
Felodipine—Vertigo—Doxorubicin—breast cancer	3.98e-05	0.000266	CcSEcCtD
Felodipine—Syncope—Doxorubicin—breast cancer	3.97e-05	0.000266	CcSEcCtD
Felodipine—Pruritus—Capecitabine—breast cancer	3.97e-05	0.000266	CcSEcCtD
Felodipine—Diarrhoea—Docetaxel—breast cancer	3.96e-05	0.000265	CcSEcCtD
Felodipine—Confusional state—Epirubicin—breast cancer	3.94e-05	0.000264	CcSEcCtD
Felodipine—Palpitations—Doxorubicin—breast cancer	3.91e-05	0.000262	CcSEcCtD
Felodipine—Loss of consciousness—Doxorubicin—breast cancer	3.89e-05	0.000261	CcSEcCtD
Felodipine—Cough—Doxorubicin—breast cancer	3.86e-05	0.000259	CcSEcCtD
Felodipine—Shock—Epirubicin—breast cancer	3.84e-05	0.000257	CcSEcCtD
Felodipine—Diarrhoea—Capecitabine—breast cancer	3.84e-05	0.000257	CcSEcCtD
Felodipine—Dizziness—Docetaxel—breast cancer	3.83e-05	0.000256	CcSEcCtD
Felodipine—Tachycardia—Epirubicin—breast cancer	3.81e-05	0.000255	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Methotrexate—breast cancer	3.8e-05	0.000255	CcSEcCtD
Felodipine—Insomnia—Methotrexate—breast cancer	3.77e-05	0.000253	CcSEcCtD
Felodipine—Myalgia—Doxorubicin—breast cancer	3.77e-05	0.000252	CcSEcCtD
Felodipine—Chest pain—Doxorubicin—breast cancer	3.77e-05	0.000252	CcSEcCtD
Felodipine—Arthralgia—Doxorubicin—breast cancer	3.77e-05	0.000252	CcSEcCtD
Felodipine—Paraesthesia—Methotrexate—breast cancer	3.75e-05	0.000251	CcSEcCtD
Felodipine—Dyspnoea—Methotrexate—breast cancer	3.72e-05	0.000249	CcSEcCtD
Felodipine—Somnolence—Methotrexate—breast cancer	3.71e-05	0.000248	CcSEcCtD
Felodipine—Dizziness—Capecitabine—breast cancer	3.71e-05	0.000248	CcSEcCtD
Felodipine—Dry mouth—Doxorubicin—breast cancer	3.69e-05	0.000247	CcSEcCtD
Felodipine—Vomiting—Docetaxel—breast cancer	3.68e-05	0.000246	CcSEcCtD
Felodipine—Dyspepsia—Methotrexate—breast cancer	3.67e-05	0.000246	CcSEcCtD
Felodipine—Rash—Docetaxel—breast cancer	3.65e-05	0.000244	CcSEcCtD
Felodipine—Dermatitis—Docetaxel—breast cancer	3.65e-05	0.000244	CcSEcCtD
Felodipine—Confusional state—Doxorubicin—breast cancer	3.64e-05	0.000244	CcSEcCtD
Felodipine—Headache—Docetaxel—breast cancer	3.63e-05	0.000243	CcSEcCtD
Felodipine—Fatigue—Methotrexate—breast cancer	3.6e-05	0.000241	CcSEcCtD
Felodipine—Vomiting—Capecitabine—breast cancer	3.56e-05	0.000239	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Epirubicin—breast cancer	3.56e-05	0.000238	CcSEcCtD
Felodipine—Shock—Doxorubicin—breast cancer	3.56e-05	0.000238	CcSEcCtD
Felodipine—Rash—Capecitabine—breast cancer	3.53e-05	0.000237	CcSEcCtD
Felodipine—Insomnia—Epirubicin—breast cancer	3.53e-05	0.000236	CcSEcCtD
Felodipine—Dermatitis—Capecitabine—breast cancer	3.53e-05	0.000236	CcSEcCtD
Felodipine—Tachycardia—Doxorubicin—breast cancer	3.53e-05	0.000236	CcSEcCtD
Felodipine—Headache—Capecitabine—breast cancer	3.51e-05	0.000235	CcSEcCtD
Felodipine—Paraesthesia—Epirubicin—breast cancer	3.51e-05	0.000235	CcSEcCtD
Felodipine—Dyspnoea—Epirubicin—breast cancer	3.48e-05	0.000233	CcSEcCtD
Felodipine—Somnolence—Epirubicin—breast cancer	3.47e-05	0.000232	CcSEcCtD
Felodipine—Nausea—Docetaxel—breast cancer	3.44e-05	0.00023	CcSEcCtD
Felodipine—Feeling abnormal—Methotrexate—breast cancer	3.44e-05	0.00023	CcSEcCtD
Felodipine—Dyspepsia—Epirubicin—breast cancer	3.44e-05	0.00023	CcSEcCtD
Felodipine—Gastrointestinal pain—Methotrexate—breast cancer	3.41e-05	0.000228	CcSEcCtD
Felodipine—Fatigue—Epirubicin—breast cancer	3.37e-05	0.000225	CcSEcCtD
Felodipine—Constipation—Epirubicin—breast cancer	3.34e-05	0.000224	CcSEcCtD
Felodipine—Nausea—Capecitabine—breast cancer	3.33e-05	0.000223	CcSEcCtD
Felodipine—Urticaria—Methotrexate—breast cancer	3.32e-05	0.000222	CcSEcCtD
Felodipine—Abdominal pain—Methotrexate—breast cancer	3.3e-05	0.000221	CcSEcCtD
Felodipine—Body temperature increased—Methotrexate—breast cancer	3.3e-05	0.000221	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.29e-05	0.00022	CcSEcCtD
Felodipine—Insomnia—Doxorubicin—breast cancer	3.27e-05	0.000219	CcSEcCtD
Felodipine—Paraesthesia—Doxorubicin—breast cancer	3.25e-05	0.000217	CcSEcCtD
Felodipine—Dyspnoea—Doxorubicin—breast cancer	3.22e-05	0.000216	CcSEcCtD
Felodipine—Feeling abnormal—Epirubicin—breast cancer	3.22e-05	0.000215	CcSEcCtD
Felodipine—Somnolence—Doxorubicin—breast cancer	3.21e-05	0.000215	CcSEcCtD
Felodipine—Gastrointestinal pain—Epirubicin—breast cancer	3.19e-05	0.000214	CcSEcCtD
Felodipine—Dyspepsia—Doxorubicin—breast cancer	3.18e-05	0.000213	CcSEcCtD
Felodipine—Fatigue—Doxorubicin—breast cancer	3.12e-05	0.000209	CcSEcCtD
Felodipine—Urticaria—Epirubicin—breast cancer	3.1e-05	0.000208	CcSEcCtD
Felodipine—Constipation—Doxorubicin—breast cancer	3.09e-05	0.000207	CcSEcCtD
Felodipine—Abdominal pain—Epirubicin—breast cancer	3.09e-05	0.000207	CcSEcCtD
Felodipine—Body temperature increased—Epirubicin—breast cancer	3.09e-05	0.000207	CcSEcCtD
Felodipine—Hypersensitivity—Methotrexate—breast cancer	3.07e-05	0.000206	CcSEcCtD
Felodipine—Asthenia—Methotrexate—breast cancer	2.99e-05	0.0002	CcSEcCtD
Felodipine—Feeling abnormal—Doxorubicin—breast cancer	2.98e-05	0.000199	CcSEcCtD
Felodipine—Gastrointestinal pain—Doxorubicin—breast cancer	2.96e-05	0.000198	CcSEcCtD
Felodipine—Pruritus—Methotrexate—breast cancer	2.95e-05	0.000198	CcSEcCtD
Felodipine—Hypersensitivity—Epirubicin—breast cancer	2.88e-05	0.000193	CcSEcCtD
Felodipine—Urticaria—Doxorubicin—breast cancer	2.87e-05	0.000192	CcSEcCtD
Felodipine—Body temperature increased—Doxorubicin—breast cancer	2.86e-05	0.000191	CcSEcCtD
Felodipine—Abdominal pain—Doxorubicin—breast cancer	2.86e-05	0.000191	CcSEcCtD
Felodipine—Diarrhoea—Methotrexate—breast cancer	2.86e-05	0.000191	CcSEcCtD
Felodipine—Asthenia—Epirubicin—breast cancer	2.8e-05	0.000188	CcSEcCtD
Felodipine—Pruritus—Epirubicin—breast cancer	2.76e-05	0.000185	CcSEcCtD
Felodipine—Dizziness—Methotrexate—breast cancer	2.76e-05	0.000185	CcSEcCtD
Felodipine—Diarrhoea—Epirubicin—breast cancer	2.67e-05	0.000179	CcSEcCtD
Felodipine—Hypersensitivity—Doxorubicin—breast cancer	2.66e-05	0.000178	CcSEcCtD
Felodipine—Vomiting—Methotrexate—breast cancer	2.65e-05	0.000178	CcSEcCtD
Felodipine—Rash—Methotrexate—breast cancer	2.63e-05	0.000176	CcSEcCtD
Felodipine—Dermatitis—Methotrexate—breast cancer	2.63e-05	0.000176	CcSEcCtD
Felodipine—Headache—Methotrexate—breast cancer	2.61e-05	0.000175	CcSEcCtD
Felodipine—Asthenia—Doxorubicin—breast cancer	2.59e-05	0.000174	CcSEcCtD
Felodipine—Dizziness—Epirubicin—breast cancer	2.58e-05	0.000173	CcSEcCtD
Felodipine—Pruritus—Doxorubicin—breast cancer	2.56e-05	0.000171	CcSEcCtD
Felodipine—Vomiting—Epirubicin—breast cancer	2.48e-05	0.000166	CcSEcCtD
Felodipine—Nausea—Methotrexate—breast cancer	2.48e-05	0.000166	CcSEcCtD
Felodipine—Diarrhoea—Doxorubicin—breast cancer	2.47e-05	0.000166	CcSEcCtD
Felodipine—Rash—Epirubicin—breast cancer	2.46e-05	0.000165	CcSEcCtD
Felodipine—Dermatitis—Epirubicin—breast cancer	2.46e-05	0.000165	CcSEcCtD
Felodipine—Headache—Epirubicin—breast cancer	2.45e-05	0.000164	CcSEcCtD
Felodipine—Dizziness—Doxorubicin—breast cancer	2.39e-05	0.00016	CcSEcCtD
Felodipine—Nausea—Epirubicin—breast cancer	2.32e-05	0.000155	CcSEcCtD
Felodipine—Vomiting—Doxorubicin—breast cancer	2.3e-05	0.000154	CcSEcCtD
Felodipine—Rash—Doxorubicin—breast cancer	2.28e-05	0.000153	CcSEcCtD
Felodipine—Dermatitis—Doxorubicin—breast cancer	2.28e-05	0.000152	CcSEcCtD
Felodipine—Headache—Doxorubicin—breast cancer	2.26e-05	0.000152	CcSEcCtD
Felodipine—Nausea—Doxorubicin—breast cancer	2.15e-05	0.000144	CcSEcCtD
Felodipine—CALM2—Metabolism—PIK3CB—breast cancer	9.99e-07	6.86e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—STAT3—breast cancer	9.99e-07	6.86e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—STAT3—breast cancer	9.99e-07	6.86e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—IGF1—breast cancer	9.99e-07	6.85e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—IGF1—breast cancer	9.99e-07	6.85e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—AKT2—breast cancer	9.98e-07	6.85e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—AKT2—breast cancer	9.98e-07	6.85e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—STK11—breast cancer	9.97e-07	6.84e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CYP19A1—breast cancer	9.97e-07	6.84e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—EGFR—breast cancer	9.94e-07	6.82e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—EGFR—breast cancer	9.94e-07	6.82e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CD—breast cancer	9.91e-07	6.8e-06	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PTGS2—breast cancer	9.9e-07	6.8e-06	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PTGS2—breast cancer	9.9e-07	6.8e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—SRC—breast cancer	9.89e-07	6.79e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—MAPK3—breast cancer	9.86e-07	6.77e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—SERPINE1—breast cancer	9.8e-07	6.73e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—NOS3—breast cancer	9.74e-07	6.68e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—KRAS—breast cancer	9.7e-07	6.66e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CG—breast cancer	9.63e-07	6.61e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CD—breast cancer	9.59e-07	6.58e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CD—breast cancer	9.59e-07	6.58e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—SRC—breast cancer	9.56e-07	6.56e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—SRC—breast cancer	9.56e-07	6.56e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CG—breast cancer	9.55e-07	6.55e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—MAPK3—breast cancer	9.54e-07	6.55e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—MAPK3—breast cancer	9.54e-07	6.55e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—STAT3—breast cancer	9.53e-07	6.54e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—SERPINE1—breast cancer	9.48e-07	6.51e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—SERPINE1—breast cancer	9.48e-07	6.51e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—KRAS—breast cancer	9.39e-07	6.44e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—KRAS—breast cancer	9.39e-07	6.44e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—EGFR—breast cancer	9.38e-07	6.44e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—NOS3—breast cancer	9.36e-07	6.42e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—COMT—breast cancer	9.27e-07	6.36e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GSTP1—breast cancer	9.23e-07	6.33e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—STAT3—breast cancer	9.22e-07	6.33e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—STAT3—breast cancer	9.22e-07	6.33e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—MAPK3—breast cancer	9.11e-07	6.25e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—HMOX1—breast cancer	9.1e-07	6.25e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—EGFR—breast cancer	9.08e-07	6.23e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—EGFR—breast cancer	9.08e-07	6.23e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ITPR1—breast cancer	9.08e-07	6.23e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—NOS3—breast cancer	9.05e-07	6.21e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—NOS3—breast cancer	9.05e-07	6.21e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CB—breast cancer	8.99e-07	6.17e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CD—breast cancer	8.98e-07	6.17e-06	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—PTEN—breast cancer	8.97e-07	6.15e-06	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PTEN—breast cancer	8.93e-07	6.13e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—PIK3CA—breast cancer	8.91e-07	6.12e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PTGS2—breast cancer	8.9e-07	6.11e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MDM2—breast cancer	8.88e-07	6.09e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—ALB—breast cancer	8.87e-07	6.09e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—KRAS—breast cancer	8.87e-07	6.09e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—MYC—breast cancer	8.86e-07	6.08e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—RAF1—breast cancer	8.85e-07	6.07e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—TGFB1—breast cancer	8.84e-07	6.07e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—MAPK3—breast cancer	8.81e-07	6.05e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—MAPK3—breast cancer	8.81e-07	6.05e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—RELA—breast cancer	8.81e-07	6.05e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—ERBB2—breast cancer	8.75e-07	6.01e-06	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—PIK3CA—breast cancer	8.75e-07	6.01e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ABCB1—breast cancer	8.73e-07	5.99e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—EGFR—breast cancer	8.66e-07	5.95e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CB—breast cancer	8.64e-07	5.93e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MTOR—breast cancer	8.64e-07	5.93e-06	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PTEN—breast cancer	8.64e-07	5.93e-06	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PTEN—breast cancer	8.64e-07	5.93e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—PIK3CA—breast cancer	8.62e-07	5.92e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—PIK3CA—breast cancer	8.62e-07	5.92e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MDM2—breast cancer	8.59e-07	5.9e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MDM2—breast cancer	8.59e-07	5.9e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—TYMS—breast cancer	8.58e-07	5.89e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—KRAS—breast cancer	8.58e-07	5.89e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—KRAS—breast cancer	8.58e-07	5.89e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—MYC—breast cancer	8.57e-07	5.88e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—MYC—breast cancer	8.57e-07	5.88e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—RAF1—breast cancer	8.56e-07	5.87e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—RAF1—breast cancer	8.56e-07	5.87e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—TGFB1—breast cancer	8.55e-07	5.87e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—TGFB1—breast cancer	8.55e-07	5.87e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—RELA—breast cancer	8.52e-07	5.85e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—RELA—breast cancer	8.52e-07	5.85e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—NOS3—breast cancer	8.48e-07	5.82e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GSTM1—breast cancer	8.48e-07	5.82e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—NCOR1—breast cancer	8.48e-07	5.82e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PLA2G4A—breast cancer	8.48e-07	5.82e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—ERBB2—breast cancer	8.47e-07	5.81e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—ERBB2—breast cancer	8.47e-07	5.81e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CD—breast cancer	8.46e-07	5.81e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CD—breast cancer	8.39e-07	5.76e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—EGFR—breast cancer	8.38e-07	5.75e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—EGFR—breast cancer	8.38e-07	5.75e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CB—breast cancer	8.36e-07	5.74e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CB—breast cancer	8.36e-07	5.74e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MTOR—breast cancer	8.36e-07	5.74e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MTOR—breast cancer	8.36e-07	5.74e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—ALB—breast cancer	8.36e-07	5.74e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CXCL8—breast cancer	8.3e-07	5.7e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—ALB—breast cancer	8.28e-07	5.69e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—HRAS—breast cancer	8.25e-07	5.66e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—KRAS—breast cancer	8.19e-07	5.62e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—PIK3CA—breast cancer	8.15e-07	5.59e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GPX1—breast cancer	8.12e-07	5.57e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CDKN1B—breast cancer	8.11e-07	5.56e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CYP1A1—breast cancer	8.04e-07	5.52e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CXCL8—breast cancer	8.03e-07	5.51e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CXCL8—breast cancer	8.03e-07	5.51e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—NOS3—breast cancer	7.99e-07	5.49e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—HRAS—breast cancer	7.98e-07	5.48e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—HRAS—breast cancer	7.98e-07	5.48e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ERCC2—breast cancer	7.97e-07	5.47e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CASP3—breast cancer	7.95e-07	5.45e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—IL2—breast cancer	7.93e-07	5.45e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—NOS3—breast cancer	7.92e-07	5.44e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—KRAS—breast cancer	7.92e-07	5.43e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—KRAS—breast cancer	7.92e-07	5.43e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—IL6—breast cancer	7.89e-07	5.42e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—PIK3CA—breast cancer	7.88e-07	5.41e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—PIK3CA—breast cancer	7.88e-07	5.41e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CDKN1B—breast cancer	7.84e-07	5.38e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CDKN1B—breast cancer	7.84e-07	5.38e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CB—breast cancer	7.83e-07	5.37e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PTEN—breast cancer	7.77e-07	5.33e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PTGS2—breast cancer	7.76e-07	5.32e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CCND1—breast cancer	7.73e-07	5.31e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—JUN—breast cancer	7.72e-07	5.3e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CASP3—breast cancer	7.69e-07	5.28e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CASP3—breast cancer	7.69e-07	5.28e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—IL2—breast cancer	7.67e-07	5.27e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—IL2—breast cancer	7.67e-07	5.27e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CTNNB1—breast cancer	7.66e-07	5.26e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—IL6—breast cancer	7.64e-07	5.24e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—IL6—breast cancer	7.64e-07	5.24e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—HRAS—breast cancer	7.54e-07	5.17e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—PIK3CA—breast cancer	7.52e-07	5.16e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MMP9—breast cancer	7.51e-07	5.15e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—MTHFR—breast cancer	7.49e-07	5.14e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CDKN1A—breast cancer	7.48e-07	5.14e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CCND1—breast cancer	7.48e-07	5.14e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CCND1—breast cancer	7.48e-07	5.14e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—JUN—breast cancer	7.47e-07	5.12e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—JUN—breast cancer	7.47e-07	5.12e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PTEN—breast cancer	7.46e-07	5.12e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CTNNB1—breast cancer	7.41e-07	5.09e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CTNNB1—breast cancer	7.41e-07	5.09e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CB—breast cancer	7.38e-07	5.06e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CB—breast cancer	7.31e-07	5.02e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PTGS2—breast cancer	7.31e-07	5.02e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MAPK8—breast cancer	7.3e-07	5.01e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—HRAS—breast cancer	7.29e-07	5e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—HRAS—breast cancer	7.29e-07	5e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—AKT1—breast cancer	7.28e-07	5e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—PIK3CA—breast cancer	7.27e-07	4.99e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—PIK3CA—breast cancer	7.27e-07	4.99e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MMP9—breast cancer	7.26e-07	4.99e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MMP9—breast cancer	7.26e-07	4.99e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PTGS2—breast cancer	7.25e-07	4.97e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CDKN1A—breast cancer	7.24e-07	4.97e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CDKN1A—breast cancer	7.24e-07	4.97e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PTEN—breast cancer	7.22e-07	4.96e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PTEN—breast cancer	7.22e-07	4.96e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—IL6—breast cancer	7.21e-07	4.95e-06	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—AKT1—breast cancer	7.15e-07	4.91e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MAPK8—breast cancer	7.06e-07	4.85e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MAPK8—breast cancer	7.06e-07	4.85e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—AKT1—breast cancer	7.04e-07	4.84e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—AKT1—breast cancer	7.04e-07	4.84e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—IL6—breast cancer	6.98e-07	4.79e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—IL6—breast cancer	6.98e-07	4.79e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—HRAS—breast cancer	6.96e-07	4.78e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—SRC—breast cancer	6.92e-07	4.75e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CAV1—breast cancer	6.91e-07	4.74e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PTEN—breast cancer	6.77e-07	4.64e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—VEGFA—breast cancer	6.74e-07	4.63e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—HRAS—breast cancer	6.73e-07	4.62e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—HRAS—breast cancer	6.73e-07	4.62e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—SRC—breast cancer	6.7e-07	4.6e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—SRC—breast cancer	6.7e-07	4.6e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—STAT3—breast cancer	6.68e-07	4.58e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—IL6—breast cancer	6.66e-07	4.57e-06	CbGpPWpGaD
Felodipine—CALM3—Immune System—AKT1—breast cancer	6.65e-07	4.57e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—VEGFA—breast cancer	6.52e-07	4.48e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—VEGFA—breast cancer	6.52e-07	4.48e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—STAT3—breast cancer	6.46e-07	4.43e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—STAT3—breast cancer	6.46e-07	4.43e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—IL6—breast cancer	6.44e-07	4.42e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—IL6—breast cancer	6.44e-07	4.42e-06	CbGpPWpGaD
Felodipine—CALM1—Immune System—AKT1—breast cancer	6.44e-07	4.42e-06	CbGpPWpGaD
Felodipine—CALM2—Immune System—AKT1—breast cancer	6.44e-07	4.42e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MAPK3—breast cancer	6.38e-07	4.38e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PTEN—breast cancer	6.38e-07	4.38e-06	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—PIK3CA—breast cancer	6.33e-07	4.34e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PTEN—breast cancer	6.32e-07	4.34e-06	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PIK3CA—breast cancer	6.3e-07	4.32e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CG—breast cancer	6.3e-07	4.32e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MYC—breast cancer	6.2e-07	4.26e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—TGFB1—breast cancer	6.19e-07	4.25e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MAPK3—breast cancer	6.17e-07	4.23e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MAPK3—breast cancer	6.17e-07	4.23e-06	CbGpPWpGaD
Felodipine—CALM3—Disease—AKT1—breast cancer	6.14e-07	4.22e-06	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PIK3CA—breast cancer	6.09e-07	4.18e-06	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PIK3CA—breast cancer	6.09e-07	4.18e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—EGFR—breast cancer	6.07e-07	4.16e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MYC—breast cancer	6e-07	4.12e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MYC—breast cancer	6e-07	4.12e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—TGFB1—breast cancer	5.99e-07	4.11e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—TGFB1—breast cancer	5.99e-07	4.11e-06	CbGpPWpGaD
Felodipine—CALM2—Disease—AKT1—breast cancer	5.94e-07	4.08e-06	CbGpPWpGaD
Felodipine—CALM1—Disease—AKT1—breast cancer	5.94e-07	4.08e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—EGFR—breast cancer	5.87e-07	4.03e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—EGFR—breast cancer	5.87e-07	4.03e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—KRAS—breast cancer	5.73e-07	3.93e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—KRAS—breast cancer	5.54e-07	3.81e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—KRAS—breast cancer	5.54e-07	3.81e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CD—breast cancer	5.53e-07	3.8e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CA—breast cancer	5.48e-07	3.76e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ALB—breast cancer	5.46e-07	3.75e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CA—breast cancer	5.27e-07	3.61e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—NOS3—breast cancer	5.23e-07	3.59e-06	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—AKT1—breast cancer	5.17e-07	3.55e-06	CbGpPWpGaD
Felodipine—CALM3—Metabolism—AKT1—breast cancer	5.14e-07	3.53e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—TP53—breast cancer	5.09e-07	3.5e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CA—breast cancer	5.09e-07	3.5e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CA—breast cancer	5.09e-07	3.5e-06	CbGpPWpGaD
Felodipine—CALM1—Metabolism—AKT1—breast cancer	4.98e-07	3.42e-06	CbGpPWpGaD
Felodipine—CALM2—Metabolism—AKT1—breast cancer	4.98e-07	3.42e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—TP53—breast cancer	4.93e-07	3.38e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—TP53—breast cancer	4.93e-07	3.38e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—HRAS—breast cancer	4.87e-07	3.34e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CB—breast cancer	4.82e-07	3.31e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PTGS2—breast cancer	4.78e-07	3.28e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CA—breast cancer	4.77e-07	3.28e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—HRAS—breast cancer	4.71e-07	3.24e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—HRAS—breast cancer	4.71e-07	3.24e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—IL6—breast cancer	4.66e-07	3.2e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—IL6—breast cancer	4.51e-07	3.1e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—IL6—breast cancer	4.51e-07	3.1e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CA—breast cancer	4.5e-07	3.09e-06	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—AKT1—breast cancer	4.48e-07	3.07e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CA—breast cancer	4.46e-07	3.06e-06	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—AKT1—breast cancer	4.3e-07	2.95e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PTEN—breast cancer	4.17e-07	2.86e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—AKT1—breast cancer	4.16e-07	2.86e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—AKT1—breast cancer	4.16e-07	2.86e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—AKT1—breast cancer	3.9e-07	2.68e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—AKT1—breast cancer	3.67e-07	2.52e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—AKT1—breast cancer	3.64e-07	2.5e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CA—breast cancer	2.94e-07	2.02e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—AKT1—breast cancer	2.4e-07	1.65e-06	CbGpPWpGaD
